SCM
FRTX

Stonepine Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Stonepine Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,261
Closed -$147K – 19
2020
Q2 		$147K Buy
+3,261
New +$147K 0.28% 13
2018
Q1 		– Sell
-2,147
Closed -$1.24M – 37
2017
Q4 		$1.24M Buy
+2,147
New +$1.24M 0.74% 23